{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:39:14Z","timestamp":1788273554601,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","cpcardiology.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.cpcardiol.2017.04.003","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T01:32:41Z","timestamp":1492133561000},"page":"10-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Cardiac Amyloidosis: An Updated Review With Emphasis on Diagnosis and Future Directions"],"prefix":"10.1016","volume":"43","author":[{"given":"Sukhdeep","family":"Bhogal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatsal","family":"Ladia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Sitwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Ramu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timir K.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2017.04.003_bib1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The amyloid state of proteins in human diseases","volume":"148","author":"Eisenberg","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120308998998","article-title":"Tabulation of human transthyretin (TTR) variants, 2003","volume":"10","author":"Connors","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1532-5415.2011.03868.x","article-title":"Transthyretin cardiac amyloidoses in older North Americans","volume":"60","author":"Dharmarajan","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib4","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","article-title":"Senile systemic amyloidosis presenting with heart failure: a comparison with light chain\u2013associated amyloidosis","volume":"165","author":"Ng","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/13506129.2014.964858","article-title":"Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis","volume":"21","author":"Sipe","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib6","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans","volume":"336","author":"Jacobson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib8","first-page":"372","article-title":"Ethnic distribution of amyloidosis: an autopsy study","volume":"2","author":"Buck","year":"1989","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/13506129.2015.1135792","article-title":"Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis","volume":"23","author":"Nakagawa","year":"2016","journal-title":"Amyloid"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib11","first-page":"817","article-title":"Senile systemic amyloidosis","volume":"66","author":"Yazaki","year":"2014","journal-title":"Brain Nerve"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib12","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0002-9149(97)00653-X","article-title":"Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis","volume":"80","author":"Chamarthi","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib13","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0735-1097(84)80436-2","article-title":"Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities","volume":"3","author":"Falk","year":"1984","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9343(00)00471-X","article-title":"Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis","volume":"109","author":"Mueller","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0002-9149(00)00870-5","article-title":"Left atrial kinetic energy in AL amyloidosis: can it detect early dysfunction?","volume":"86","author":"Murphy","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1309\/LYWM47K2L8XYFFB3","article-title":"Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis","volume":"119","author":"Abraham","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1515\/cclm-2015-0985","article-title":"The impact of renal function on the clinical performance of FLC measurement in AL amyloidosis","volume":"54","author":"Palladini","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib19","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1515\/cclm-2015-0917","article-title":"Monitoring free light chains in serum using mass spectrometry","volume":"54","author":"Barnidge","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib20","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2004-01-0390","article-title":"Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib21","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","article-title":"Serum N-terminal pro\u2013brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis","volume":"107","author":"Palladini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib22","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1200\/JCO.2009.23.8220","article-title":"Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis","volume":"28","author":"Kastritis","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10741-014-9464-5","article-title":"Natural history and therapy of AL cardiac amyloidosis","volume":"20","author":"Grogan","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1373\/clinchem.2011.173369","article-title":"Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial","volume":"58","author":"Kohli","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib25","first-page":"606","article-title":"Electrocardiographic and echocardiographic features of patients with primary cardiac amyloidosis","volume":"38","author":"Cheng","year":"2010","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0002-8703(49)90562-1","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads","volume":"37","author":"Sokolow","year":"1949","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib27","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.amjcard.2014.07.026","article-title":"Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis","volume":"114","author":"Cyrille","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijcard.2016.04.030","article-title":"Are classic predictors of voltage valid in cardiac amyloidosis? A contemporary analysis of electrocardiographic findings","volume":"214","author":"Sperry","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1536\/ihj.15-005","article-title":"Contribution of electrocardiogram in the differentiation of cardiac amyloidosis and nonobstructive hypertrophic cardiomyopathy","volume":"56","author":"Huang","year":"2015","journal-title":"Int Heart J"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","article-title":"Cardiac amyloidosis: the great pretender","volume":"20","author":"Rapezzi","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib31","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/01.CIR.83.3.808","article-title":"Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study","volume":"83","author":"Klein","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","article-title":"Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a prospective, observational cohort study","volume":"133","author":"Connors","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13506129.2014.994202","article-title":"The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis","volume":"22","author":"Tendler","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13506120902879681","article-title":"Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis","volume":"16","author":"Porciani","year":"2009","journal-title":"Amyloid"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12350-013-9800-5","article-title":"Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques","volume":"21","author":"Aljaroudi","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib36","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jmri.23756","article-title":"MR assessment of regional myocardial mechanics","volume":"37","author":"Simpson","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-016-0752-7","article-title":"Recent advances in cardiovascular imaging relevant to the management of patients with suspected cardiac amyloidosis","volume":"18","author":"White","year":"2016","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib38","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib41","doi-asserted-by":"crossref","first-page":"W256","DOI":"10.2214\/AJR.12.8737","article-title":"Comparison between 99mTc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy","volume":"200","author":"Minutoli","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","article-title":"CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis","volume":"7","author":"White","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib43","first-page":"126","article-title":"Myocardial T1 mapping: modalities and clinical applications","volume":"4","author":"Jellis","year":"2014","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib44","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib45","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib46","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF00998166","article-title":"Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis","volume":"16","author":"Janssen","year":"1990","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib48","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00259-010-1642-7","article-title":"Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy","volume":"38","author":"Rapezzi","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib49","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib50","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s12149-012-0627-y","article-title":"Novel method for quantitative evaluation of cardiac amyloidosis using 201TlCl and 99mTc-PYP SPECT","volume":"26","author":"Yamamoto","year":"2012","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.cpcardiol.2017.04.003_bib52","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study","volume":"57","author":"Law","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib53","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib54","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archinte.1983.00350080055015","article-title":"Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis","volume":"143","author":"Libbey","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib55","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/dc.10370","article-title":"Fine-needle aspiration of abdominal fat pad for amyloid detection: a clinically useful test?","volume":"30","author":"Ansari-Lari","year":"2004","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib56","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ahj.2003.09.020","article-title":"Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy","volume":"147","author":"Ardehali","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib57","first-page":"529","article-title":"The workings of the amyloid diseases","volume":"114","author":"Bellotti","year":"2007","journal-title":"Ann Med"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib58","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/0002-9149(85)90995-6","article-title":"Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents","volume":"55","author":"Gertz","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib59","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","article-title":"Digoxin sensitivity in amyloid cardiomyopathy","volume":"63","author":"Rubinow","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib60","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1378\/chest.124.3.969","article-title":"Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis","volume":"124","author":"Berk","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib61","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/jce.12123","article-title":"Implantable cardioverter defibrillators in patients with cardiac amyloidosis","volume":"24","author":"Lin","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib62","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death","volume":"5","author":"Kristen","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib63","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1182\/blood-2015-01-620302","article-title":"A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis","volume":"126","author":"Palladini","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib64","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/leu.2014.227","article-title":"Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients","volume":"28","author":"Palladini","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib65","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/leu.2012.274","article-title":"Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis","volume":"27","author":"Landau","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib66","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3324\/haematol.2013.095463","article-title":"Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach","volume":"99","author":"Palladini","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib67","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/blood-2006-07-035352","article-title":"Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis","volume":"109","author":"Wechalekar","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib68","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2012-12-473066","article-title":"A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis","volume":"121","author":"Wechalekar","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib69","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9149(99)80214-8","article-title":"Recurrence of primary (AL) amyloidosis in a transplanted heart with four-year survival","volume":"76","author":"Dubrey","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib70","first-page":"Iii338","article-title":"Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey","volume":"84","author":"Hosenpud","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib71","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.healun.2008.05.016","article-title":"Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy","volume":"27","author":"Lacy","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib72","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/TP.0b013e3181f10edb","article-title":"Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure","volume":"90","author":"Dey","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib73","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5500\/wjt.v6.i2.380","article-title":"Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: the Mayo Clinic experience","volume":"6","author":"Grogan","year":"2016","journal-title":"World J Transplant"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/lt.24058","article-title":"Liver transplantation in transthyretin amyloidosis: issues and challenges","volume":"21","author":"Carvalho","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib75","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","article-title":"Liver transplantation for hereditary transthyretin amyloidosis: after 20 years still the best therapeutic alternative?","volume":"99","author":"Ericzon","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib76","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00007890-199707150-00014","article-title":"Progression of ventricular wall thickening after liver transplantation for familial amyloidosis","volume":"64","author":"Dubrey","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib77","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00007890-199807270-00016","article-title":"Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis","volume":"66","author":"Stangou","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/TP.0b013e3181ac60db","article-title":"Combined heart and liver transplantation: a single-center experience","volume":"88","author":"Raichlin","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib79","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/13506129.2013.853660","article-title":"Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis","volume":"21","author":"Thenappan","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jmb.2011.12.060","article-title":"The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug","volume":"421","author":"Johnson","year":"2012","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib81","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neures.2006.08.014","article-title":"Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis","volume":"56","author":"Tojo","year":"2006","journal-title":"Neurosci Res"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib82","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/ene.12225","article-title":"Effect on disability and safety of tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy","volume":"20","author":"Lozeron","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib83","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib84","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1600-6143.2005.00805.x","article-title":"Heart transplantation in a 68-year-old patient with senile systemic amyloidosis","volume":"5","author":"Fuchs","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib85","doi-asserted-by":"crossref","first-page":"26623","DOI":"10.1038\/srep26623","article-title":"Curcumin: a multi-target disease-modifying agent for late-stage transthyretin amyloidosis","volume":"6","author":"Ferreira","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib86","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.2147\/DDDT.S96893","article-title":"Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study","volume":"9","author":"aus dem","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib87","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib88","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/mus.20503","article-title":"Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides","volume":"33","author":"Benson","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cpcardiol.2017.04.003_bib89","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1479-5876-8-74","article-title":"Synergy of combined doxycycline\/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models","volume":"8","author":"Cardoso","year":"2010","journal-title":"J Transl Med"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280617300701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280617300701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T13:47:07Z","timestamp":1601905627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280617300701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0146280617300701"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2017.04.003","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Amyloidosis: An Updated Review With Emphasis on Diagnosis and Future Directions","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2017.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}